Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery

Protein Science

Volumn 21, Issue 11, 2012, Pages 1734-1745

  Lindert, Steffen ^a,b   McCammon, J Andrew ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NSF Center for Theoretical Biological Physics   (United States)

Author keywords

Computer aided drug discovery; Enoyl acyl carrier protein reductase; Molecular dynamics; Protein drug interactions

Indexed keywords

ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH);

ARTICLE; ENZYME BINDING; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

BINDING SITES; COMPUTER-AIDED DESIGN; DRUG DISCOVERY; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); HYDROGEN BONDING; LIGANDS; MOLECULAR DYNAMICS SIMULATION; NAD; PLASMODIUM FALCIPARUM; PROTEIN BINDING; TRICLOSAN;

EID: 84867668195     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2155     Document Type: Article

References (40)

1. Pidugu LS, Kapoor M, Surolia N, Surolia A, Suguna K (2004) Structural basis for the variation in triclosan affinity to enoyl reductases. J Mol Biol 343:147-155. (Pubitemid 39277454)
2. Massengo-Tiasse RP, Cronan JE (2009) Diversity in enoyl-acyl carrier protein reductases. Cell Mol Life Sci 66:1507-1517.
3. Lu H, Tonge PJ (2008) Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Acc Chem Res 41:11-20.
4. Rich SM, Leendertz FH, Xu G, LeBreton M, Djoko CF, Aminake MN, Takang EE, Diffo JL, Pike BL, Rosenthal BM, Formenty P, Boesch C, Ayala FJ, Wolfe ND. (2009) The origin of malignant malaria. Proc Natl Acad Sci USA 106:14902-14907.
5. Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA, Mistry A, Timms D, Camble R, Hales NJ, Britton CJ, Taylor IW. (1999) Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry 38:12514-12525.
6. Oliveira JS, Vasconcelos IB, Moreira IS, Santos DS, Basso LA (2007) Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents. Curr Drug Targets 8:399-411. (Pubitemid 46388895)
7. Heath RJ, Rock CO (1995) Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli. J Biol Chem 270:26538-26542.
8. Singh NJ, Shin D, Lee HM, Kim HT, Chang HJ, Cho JM, Kim KS, Ro S. (2011) Structural basis of triclosan resistance. J Struct Biol 174:173-179.
9. Lu X, Huang K, You Q (2011) Enoyl acyl carrier protein reductase inhibitors: a patent review (2006-2010). Expert Opin Ther Pat 21:1007-1022.
10. Qiu X, Janson CA, Court RI, Smyth MG, Payne DJ, Abdel-Meguid SS (1999) Molecular basis for triclosan activity involves a flipping loop in the active site. Prot Sci 8:2529-2532. (Pubitemid 29536423)
11. Heath RJ, Yu YT, Shapiro MA, Olson E, Rock CO (1998) Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 273:30316-30320. (Pubitemid 28545500)
12. Bhargava HN, Leonard PA (1996) Triclosan: applications and safety. Am J Infect Control 24:209-218. (Pubitemid 26231023)
13. Kapoor M, Dar MJ, Surolia A, Surolia N (2001) Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem Biophys Res Commun 289:832-837. (Pubitemid 34060079)
14. Kapoor M, Reddy CC, Krishnasastry MV, Surolia N, Surolia A (2004) Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem J 381:719-724. (Pubitemid 39120481)
15. Lee HM, Singh NJ (2011) Understanding drug-protein interactions in Escherichia coli FabI and various FabI inhibitor complexes. B Korean Chem Soc 32:162-168.
16. Pasqualoto KFM, Ferreira MMC (2006) Application of a receptor pruning methodology to the enoyl-ACP reductase from Escherichia coli (Fabl). Qsar Comb Sci 25:629-636. (Pubitemid 44113879)
17. Yang L, Liu Y, Sternberg C, Molin S (2010) Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents. Molecules 15:780-792.
18. de Azevedo WF, Jr. (2011) Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis. Curr Med Chem 18:1353-1366.
19. Sinko W, de Oliveira C, Williams S, Van Wynsberghe A, Durrant JD, Cao R, Oldfield E, McCammon JA. (2011) Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target. Chem Biol Drug Des 77:412-420.
20. Maity K, Banerjee T, Prabakaran N, Surolia N, Surolia A, Suguna K (2011) Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum. IUBMB Life 63:30-41.
21. Maity K, Bhargav SP, Sankaran B, Surolia N, Surolia A, Suguna K (2010) X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. IUBMB Life 62:467-476.
22. Wallwork SC (1962) Hydrogen-bond radii. Acta Cryst 15:758-759.
23. Sinnokrot MO, Valeev EF, Sherrill CD (2002) Estimates of the ab initio limit for pi-pi interactions: the benzene dimer. J Am Chem Soc 124:10887-10893.
24. Brenke R, Kozakov D, Chuang GY, Beglov D, Hall D, Landon MR, Mattos C, Vajda S. (2009) Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics 25:621-627.
25. Schames JR, Henchman RH, Siegel JS, Sotriffer CA, Ni H, McCammon JA (2004) Discovery of a novel binding trench in HIV integrase. J Med Chem 47:1879-1881. (Pubitemid 38453905)
26. Amaro R, Baron R, McCammon J (2008) An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comp Mol Des 22:693-705.
27. Lin JH, Perryman AL, Schames JR, McCammon JA (2002) Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J Am Chem Soc 124:5632-5633. (Pubitemid 34533490)
28. Lin JH, Perryman AL, Schames JR, McCammon JA (2003) The relaxed complex method: accommodating receptor flexibility for drug design with an improved scoring scheme. Biopolymers 68:47-62. (Pubitemid 36098307)
29. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201. (Pubitemid 43205406)
30. Perozzo R, Kuo M, Sidhu AS, Valiyaveettil JT, Bittman R, Jacobs WR, Jr, Fidock DA, Sacchettini JC. (2002) Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 277:13106-13114. (Pubitemid 34952681)
31. Muench SP, Prigge ST, McLeod R, Rafferty JB, Kirisits MJ, Roberts CW, Mui EJ, Rice DW. (2007) Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Cryst D63:328-338. (Pubitemid 46438526)
32. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. (2004) UCSF Chimera - a visualization system for exploratory research and analysis. J Comp Chem 25:1605-1612.
33. Case DA, Cheatham TE, III, Darden T, Gohlke H, Luo R, Merz KM, Jr, Onufriev A, Simmerling C, Wang B, Woods RJ. (2005) The Amber biomolecular simulation programs. J Comp Chem 26:1668-1688. (Pubitemid 43076180)
34. Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65:712-725. (Pubitemid 44583220)
35. Ryckaert J-P, Ciccotti G, Berendsen HJC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comp Phys 23:327-341.
36. Grant BJ, Rodrigues AP, ElSawy KM, McCammon JA, Caves LS (2006) Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 22:2695-2696. (Pubitemid 44642612)
37. Abseher R, Nilges M (1998) Are there non-trivial dynamic cross-correlations in proteins? J Mol Biol 279:911-920. (Pubitemid 28284705)
38. van Aalten DMF, DeGroot BL, Findlay JBC, Berendsen HJC, Amadei A (1997) A comparison of techniques for calculating protein essential dynamics. J Comp Chem 18:169-181. (Pubitemid 127598563)
39. Durrant JD, de Oliveira CA, McCammon JA (2011) POVME: an algorithm for measuring binding-pocket volumes. J Mol Graph Model 29:773-776.
40. Christen M, Hunenberger PH, Bakowies D, Baron R, Burgi R, Geerke DP, Heinz TN, Kastenholz MA, Krautler V, Oostenbrink C, Peter C, Trzesniak D, van Gunsteren WF. (2005) The GROMOS software for biomolecular simulation: GROMOS05. J Comp Chem 26:1719-1751. (Pubitemid 43076183)